REPORT ID 1381

EMEA (Europe, Middle East and Africa) Artificial Saliva Market Report 2017

Publish Date
05-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the EMEA Artificial Saliva market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Artificial Saliva for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Artificial Saliva market competition by top manufacturers/players, with Artificial Saliva sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline plc
    Cipla Limited
    Mission Pharmacal Company
    Fresenius Kabi
    Parnell Pharmaceuticals, Inc.
    CCMed Group
    Entod International
    Midatech Pharma Plc.
    Forward Science
    Valeant Pharmaceuticals International, Inc.
    Biocosmetics Laboratories
    Icpa Health Products LTD.
    Perrigo
    Laboratorios Kin, S.A.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Oral Spray
    Oral Solution
    Oral Liquid
    Gel
    Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Adult
    Paediatric

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Artificial Saliva Market Report 2017
1 Artificial Saliva Overview
    1.1 Product Overview and Scope of Artificial Saliva
    1.2 Classification of Artificial Saliva
        1.2.1 EMEA Artificial Saliva Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Artificial Saliva Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Oral Spray
        1.2.4 Oral Solution
        1.2.5 Oral Liquid
        1.2.6 Gel
        1.2.7 Powder
    1.3 EMEA Artificial Saliva Market by Application/End Users
        1.3.1 EMEA Artificial Saliva Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Adult
        1.3.3 Paediatric
    1.4 EMEA Artificial Saliva Market by Region
        1.4.1 EMEA Artificial Saliva Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Artificial Saliva (2012-2022)
        1.5.1 EMEA Artificial Saliva Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Artificial Saliva Revenue and Growth Rate (2012-2022)

2 EMEA Artificial Saliva Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Artificial Saliva Market Competition by Players/Manufacturers
        2.1.1 EMEA Artificial Saliva Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Artificial Saliva Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Artificial Saliva Sale Price by Players (2012-2017)
    2.2 EMEA Artificial Saliva (Volume and Value) by Type/Product Category
        2.2.1 EMEA Artificial Saliva Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Artificial Saliva Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Artificial Saliva Sale Price by Type (2012-2017)
    2.3 EMEA Artificial Saliva (Volume) by Application
    2.4 EMEA Artificial Saliva (Volume and Value) by Region
        2.4.1 EMEA Artificial Saliva Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Artificial Saliva Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Artificial Saliva Sales Price by Region (2012-2017)

3 Europe Artificial Saliva (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Artificial Saliva Sales and Value (2012-2017)
        3.1.1 Europe Artificial Saliva Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Artificial Saliva Revenue and Growth Rate (2012-2017)
    3.2 Europe Artificial Saliva Sales and Market Share by Type
    3.3 Europe Artificial Saliva Sales and Market Share by Application
    3.4 Europe Artificial Saliva Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Artificial Saliva Sales Volume by Countries (2012-2017)
        3.4.2 Europe Artificial Saliva Revenue by Countries (2012-2017)
        3.4.3 Germany Artificial Saliva Sales and Growth Rate (2012-2017)
        3.4.4 France Artificial Saliva Sales and Growth Rate (2012-2017)
        3.4.5 UK Artificial Saliva Sales and Growth Rate (2012-2017)
        3.4.6 Russia Artificial Saliva Sales and Growth Rate (2012-2017)
        3.4.7 Italy Artificial Saliva Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Artificial Saliva Sales and Growth Rate (2012-2017)

4 Middle East Artificial Saliva (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Artificial Saliva Sales and Value (2012-2017)
        4.1.1 Middle East Artificial Saliva Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Artificial Saliva Revenue and Growth Rate (2012-2017)
    4.2 Middle East Artificial Saliva Sales and Market Share by Type
    4.3 Middle East Artificial Saliva Sales and Market Share by Application
    4.4 Middle East Artificial Saliva Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Artificial Saliva Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Artificial Saliva Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Artificial Saliva Sales and Growth Rate (2012-2017)
        4.4.4 Israel Artificial Saliva Sales and Growth Rate (2012-2017)
        4.4.5 UAE Artificial Saliva Sales and Growth Rate (2012-2017)
        4.4.6 Iran Artificial Saliva Sales and Growth Rate (2012-2017)

5 Africa Artificial Saliva (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Artificial Saliva Sales and Value (2012-2017)
        5.1.1 Africa Artificial Saliva Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Artificial Saliva Revenue and Growth Rate (2012-2017)
    5.2 Africa Artificial Saliva Sales and Market Share by Type
    5.3 Africa Artificial Saliva Sales and Market Share by Application
    5.4 Africa Artificial Saliva Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Artificial Saliva Sales Volume by Countries (2012-2017)
        5.4.2 Africa Artificial Saliva Revenue by Countries (2012-2017)
        5.4.3 South Africa Artificial Saliva Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Artificial Saliva Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Artificial Saliva Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Artificial Saliva Sales and Growth Rate (2012-2017)

6 EMEA Artificial Saliva Manufacturers/Players Profiles and Sales Data
    6.1 GlaxoSmithKline plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Artificial Saliva Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline plc Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Cipla Limited
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Artificial Saliva Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Cipla Limited Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Mission Pharmacal Company
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Artificial Saliva Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mission Pharmacal Company Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Fresenius Kabi
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Artificial Saliva Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Fresenius Kabi Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Parnell Pharmaceuticals, Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Artificial Saliva Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Parnell Pharmaceuticals, Inc. Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 CCMed Group
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Artificial Saliva Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 CCMed Group Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Entod International
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Artificial Saliva Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Entod International Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Midatech Pharma Plc.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Artificial Saliva Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Midatech Pharma Plc. Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Forward Science
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Artificial Saliva Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Forward Science Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Valeant Pharmaceuticals International, Inc.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Artificial Saliva Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Valeant Pharmaceuticals International, Inc. Artificial Saliva Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Biocosmetics Laboratories
    6.12 Icpa Health Products LTD.
    6.13 Perrigo
    6.14 Laboratorios Kin, S.A.

7 Artificial Saliva Manufacturing Cost Analysis
    7.1 Artificial Saliva Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Artificial Saliva

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Artificial Saliva Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Artificial Saliva Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Artificial Saliva Market Forecast (2017-2022)
    11.1 EMEA Artificial Saliva Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Artificial Saliva Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Artificial Saliva Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Artificial Saliva Price and Trend Forecast (2017-2022)
    11.2 EMEA Artificial Saliva Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Artificial Saliva Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Artificial Saliva Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Artificial Saliva Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Artificial Saliva Sales Forecast by Type (2017-2022)
    11.7 EMEA Artificial Saliva Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer